No connection

Search Results

IPX

BEARISH
$31.89 Live
IperionX Limited · NASDAQ
Target $55.6 (+74.3%)
$14.62 52W Range $61.45

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 12, 2026
Market cap
$1.16B
P/E
N/A
ROE
-50.4%
Profit margin
N/A
Debt/Equity
0.04
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
IPX exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor operational health. While the company maintains a strong liquidity position with a Current Ratio of 4.03 and very low debt (D/E 0.04), it is currently plagued by severe profitability issues, including an ROE of -50.42% and a negative forward P/E. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual deterministic data, which shows a bearish technical trend (0/100) and a sharp 6-month price decline of 41.3%.

Key Strengths

Very low leverage (Debt/Equity 0.04)
Strong short-term liquidity (Current Ratio 4.03)
Strong analyst conviction (Strong Buy recommendation)
Significant historical 1-year price appreciation (+124.1%)
Substantial market capitalization for its industry niche ($1.16B)

Key Risks

Weak financial health as evidenced by Piotroski F-Score of 3/9
Extreme valuation premium (Price/Book of 9.90)
Lack of current profitability (0% margins, negative ROE/ROA)
Severe negative short-term price momentum (-35.7% in 1 month)
Absence of revenue growth data to justify the valuation

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
30
Weak
Value
15
Future
60
Past
45
Health
30
Dividend
0
AI Verdict
Speculative/High Risk
Key drivers: Piotroski F-Score, Technical Trend, Price/Book Ratio, ROE
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • P/B of 9.90 is excessive
  • Forward P/E is deeply negative
  • No Graham Number available due to lack of earnings
Future
60/100

Ref Growth rates

Positives
  • High analyst target price ($55.60)
  • Strong Buy consensus
Watchpoints
  • No reported revenue growth to support projections
Past
45/100

Ref Historical trends

Positives
  • Strong 1Y and 3Y returns
Watchpoints
  • Recent 6-month crash (-41.3%)
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Low Debt/Equity
  • High Current Ratio
Watchpoints
  • Piotroski F-Score 3/9 (Weak)
  • Negative ROE and ROA
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$31.89
Analyst Target
$55.6
Upside/Downside
+74.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for IPX and closest competitors.

Updated 2026-04-10
IPX
IperionX Limited
Primary
5Y
+353.0%
3Y
+485.1%
1Y
+124.1%
6M
-41.3%
1M
-35.7%
1W
+17.1%
ELV
Elevra Lithium Limited
Peer
5Y
+176.2%
3Y
+176.2%
1Y
+176.2%
6M
+122.1%
1M
+22.8%
1W
+2.4%
ELE
Elemental Royalty Corporation
Peer
5Y
+61.2%
3Y
+93.1%
1Y
+116.7%
6M
+10.5%
1M
-15.7%
1W
-0.8%
GPR
Green Plains Inc.
Peer
5Y
-41.5%
3Y
-52.8%
1Y
+285.6%
6M
+67.7%
1M
-3.1%
1W
-10.2%
GSM
Ferroglobe PLC
Peer
5Y
+35.9%
3Y
-5.9%
1Y
+33.0%
6M
-13.7%
1M
-13.6%
1W
+4.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-114.51
PEG Ratio
N/A
P/B Ratio
9.9
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
-204.42
Market Cap
$1.16B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE -50.41%
ROA -28.24%

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.04
Low debt
Current Ratio
4.03
Strong
Quick Ratio
3.88
Excellent
Cash/Share
$0.19

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Total Assets
$0.1B
Liabilities
$0.0B
Equity
$0.1B
Debt/Equity
0.19x

Basic Materials Sector Comparison

Comparing IPX against 65 companies in the Basic Materials sector (1 bullish, 28 neutral, 36 bearish)
Return on Equity (ROE)
-50.41%
This Stock
vs
-7.32%
Sector Avg
+588.5% (Excellent)
Debt to Equity
0.04
This Stock
vs
0.48
Sector Avg
-91.4% (Less Debt)
Current Ratio
4.03
This Stock
vs
7.83
Sector Avg
-48.5% (Weaker)

Similar Companies

Peer comparison within the same industry

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
5 analysts
BTIG
2026-03-27
init
Buy
B. Riley Securities
2026-03-13
Maintains
Buy Buy
Roth Capital
2026-01-20
reit
Buy Buy
William Blair
2026-01-13
init
Outperform

Past News Coverage

Recent headlines mentioning IPX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile